FindTrial
Sign In

Effect of intraoperative cell salvage on systemic tissue perfusion and short-term prognosis in heart valvular surgery

Effect of intraoperative cell salvage on systemic tissue perfusion and short-term prognosis in heart valvular surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060439
Enrollment
Unknown
Registered
2022-06-01
Start date
2022-07-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical heart disease

Interventions

control group:Non-Cell Saver
experimental group:Cell Saver

Sponsors

PLA Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing heart valve surgery; 2. Aged 18-65 years; 3. Stay in ICU for at least 2 days after operation.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Preoperative anemia; 3. Preoperative hepatic and renal insufficiency; 4. Have coagulation dysfunction; 5. There are infectious diseases before surgery.

Design outcomes

Primary

MeasureTime frame
lactate;—

Secondary

MeasureTime frame
total bilirubin;creatinine;ICU length of stay;hospital length of stay;—

Countries

China

Contacts

Public ContactJin Zhenxiao

PLA Air Force Military Medical University

1045151706@qq.com+86 18845767143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026